Why not treat human cancer with interleukin-1 blockade?

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.29, Iss.2, 2010-06, pp. : 317-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why are Rho proteins important in cancer?

Breast Cancer Research and Treatment, Vol. 84, Iss. 1, 2004-03 ,pp. : 1-1

Springer Publishing Company

Access to resources Recommend Favorite

How can we improve the quality of reporting family history in colorectal cancer care? (And why does it matter?)

By Wilson Brenda J

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 99-102

Future Medicine

Access to resources Recommend Favorite

Ductal carcinoma in situ: how should we treat it?

By Bayraktar Soley Arun Banu Glück Stefan

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite

Defining resectability of colorectal liver metastases: how and why?

By Voorthuizen Theo van van Gulik Thomas M Punt Cornelis JA

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 61-72

Future Medicine

Access to resources Recommend Favorite

Is ALDH1 a good method for definition of breast cancer stem cells?

By Neumeister Veronique

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite